New Flu Drug Granted Priority FDA Review
A new, fast-acting flu drug that can control flu symptoms in a single dose has been granted priority review by the US Food and Drug Administration.
3315 articles
A new, fast-acting flu drug that can control flu symptoms in a single dose has been granted priority review by the US Food and Drug Administration.
Scientists are currently investigating Xofluza, a new influenza drug created by Japanese pharmaceutical company Shionogi that was approved for clinical ...
Ben Ashby offers advice on how people should take care of their eye health. Learn more on Health Professional Radio.
A low-cost plastic sensor that can monitor and diagnose a variety of health conditions such neurodegenerative diseases has been engineered by an interna...
According to new research published in the Nature Communications journal, the blocking of interactions between influenza A (flu A) that takes control of...
The private medical information of hundreds of HealthEngine app users have been recently given to various Australian law firms for pursuing clients for...
Tahseen Mozaffar discusses the symptoms of generalized myasthenia gravis (gMG), diagnostic challenges, prognosis, and new therapeutic options for managi...
Nancy Law discusses the rare neurological disorder Myasthenia Gravis, the foundation's mission, and her own journey with this condition.
Phillip Artemi, one of Australia’s leading dermatologists and Director of The Vitiligo Centre Australia joins Health Professional Radio to promote gre...
A team of engineers from Johns Hopkins University has designed a sensory illusion to create an electronic skin that can help amputees reduce their "phan...